Clinical evaluation of microarray data

Similar documents
RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016

CHROMOSOMAL MICROARRAY (CGH+SNP)

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

Updating penetrance estimates for syndromes with variable phenotypic manifestation. Adele Corrigan June 27th

What s the Human Genome Project Got to Do with Developmental Disabilities?

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns

Clinical Genomics. Ina E. Amarillo, PhD FACMGG

Genetic Testing 101: Interpreting the Chromosomes

Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs

Dr Dipti Deshmukh. Mayu Uemura. 11th September Introduction

Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment).

Genetic Testing for Single-Gene and Multifactorial Conditions

Genetic Testing for the Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies

Chromosome Microarray Analysis (CMA)

Faravareh Khordadpoor (PhD in molecular genetics) 1- Tehran Medical Genetics Laboratory 2- Science and research branch, Islamic Azad University

Approach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD

Sharan Goobie, MD, MSc, FRCPC

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

Clinical Interpretation of Cancer Genomes

Genetics update and implications for (General) Practice

Genetics and Genomics: Applications to Developmental Disability

Case 1B. 46,XY,-14,+t(14;21)

New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads

Increasing the Sensitivity of Genomic Assays Permits a Higher Resolution Study of the Human Genome. Our Current Knowledge of Genetics and Genomics

22q11.2 DELETION SYNDROME. Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona)

Section: Medicine Effective Date: January15, 2016 Subsection: Pathology/Laboratory Original Policy Date: December 7, 2011 Subject:

Implementation of the DDD/ClinGen OGT (CytoSure v3) Microarray

Genetics and Genetic Testing for Autism:

What lies beneath: challenges in reporting SNP array results. Jonathan Waters

Protocol. Genetic Testing for Developmental Delay and Autism Spectrum Disorder

Corporate Medical Policy

Information for you about Panorama s Microdeletion Screening BROUGHT TO YOU BY:

Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology

Nature Genetics: doi: /ng Supplementary Figure 1. PCA for ancestry in SNV data.

Human Genetic Variation Copy Number Variation

Genetic Counselling in relation to genetic testing

Chromosomal Mutations

Congenital Heart Disease How much of it is genetic?

Pedigree Analysis. Genetic disorders. Dominant inheritance. Recessive inheritance. Autosomal vs. sex-linked traits. X-linked recessive inheritance

Lab Activity 36. Principles of Heredity. Portland Community College BI 233

How many disease-causing variants in a normal person? Matthew Hurles

Microarray Comparative Genomic Hybridisation (array CGH)

A Practical Update on Genetic Testing, Diagnosis, and Next Generation Treatment Approaches for Persons with Developmental Brain Disorders

Approach to the Genetic Diagnosis of Neurological Disorders

SEAMLESS CGH DIAGNOSTIC TESTING

Copy Number Variants of Uncertain Significance in Prenatal diagnosis Are the Goalposts Moving? Lisa Burvill-Holmes Bristol Genetics Laboratory

Genetics: More Than 23 and Me

Exploding Genetic Knowledge in Developmental Disabilities. Disclosures. The Genetic Principle

National Medical Policy

Global variation in copy number in the human genome

Introduction to Fetal Medicine: Genetics and Embryology

Introduction to the Genetics of Complex Disease

Genetics and Developmental Disabilities. Stuart K. Shapira, MD, PhD. Pediatric Genetics Team

CNV Detection and Interpretation in Genomic Data

MULTIPLE CHOICE QUESTIONS

JULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider

Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit

Genetic Considerations in Young Children with Developmental Delays

MLPA SAMPLES USER GUIDE

5/2/18. After this class students should be able to: Stephanie Moon, Ph.D. - GWAS. How do we distinguish Mendelian from non-mendelian traits?

Welcome to the Genetic Code: An Overview of Basic Genetics. October 24, :00pm 3:00pm

Microdeletion and Prenatal FISH Probes

THE PENNSYLVANIA STATE UNIVERSITY SCHREYER HONORS COLLEGE DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY

MOLECULAR DIAGNOSIS for X-LINKED INTELLECTUAL DISABILITY

Nature Genetics: doi: /ng Supplementary Figure 1

Investigating rare diseases with Agilent NGS solutions

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

17q12 Review. What s in a name? Spring Parental Testing: What, Why, & How. Conference Updates

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction

Structural Chromosome Aberrations

Genetic Testing for Single-Gene and Multifactorial Conditions

American Psychiatric Nurses Association

Merging single gene-level CNV with sequence variant interpretation following the ACMGG/AMP sequence variant guidelines

Molecular and Clinical Characterization of Syndromes Associated With Intellectual Disability

Syndromic X Linked Mental Retardation

Introduction to Fetal Medicine: Genetics and Embryology

Corporate Medical Policy

Prenatal Diagnosis: Are There Microarrays in Your Future?

MP Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies

Blood Types and Genetics

Analysis with SureCall 2.1

SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B

PROVIDER POLICIES & PROCEDURES

Application of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation

The Chromosomal Basis Of Inheritance

review Genetics IN Medicine 13

Medical Policy. MP Invasive Prenatal (Fetal) Diagnostic Testing

I. Multiple Alleles. Chapter 5. Summary points. What pattern of inheritance is demonstrated in the following cross?

"Current Scientists Perspectives of Autism

Information leaflet for patients and families. Uniparental Disomy (UPD)

Next Generation Children. Association for Clinical Genetic Science meeting 27th June 2017 Alba Sanchis Juan,

CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY

Mutations Quick Questions and Notes (#1) QQ#1: What do you know about mutations?

What can genetic studies tell us about ADHD? Dr Joanna Martin, Cardiff University

Unit 5 Review Name: Period:

November 9, Johns Hopkins School of Medicine, Baltimore, MD,

Transcription:

Clinical evaluation of microarray data David Amor 19 th June 2011

Single base change Microarrays 3-4Mb

What is a microarray? Up to 10 6 bits of Information!! Highly multiplexed FISH hybridisations.

Microarray Supercedes: FISH Karyotype (detection rate of 3%) The investigation of choice for: Developmental delay/ intellectual disability Autism Congenital abnormalities Pathogenic copy number changes detected in approximately 7000 referrals = 15%

Normal microarray profile A = A/T B = G/C BB AB AA Log(2) ratio: Log(2) of 1=0

Deletion

Duplication

Long continuous stretches of homozygosity Risk of recessive disease and/or UPD Only A and B Alleles ie no AB hets

CNVs are common We all have many Key task is to sort detected CNVs into four main categories: Pathogenic Uncertain significance Unknown significance Benign

Pathogenic Copy Number Change This is a well established pathogenic copy number change Already described and verified in the literature These include common microdeletion and microduplication syndromes, e.g. Prader-Willi syndrome Angelman syndrome 22q11 microdeletion syndrome (VCFS) Cri-du-chat syndrome

Copy Number Change of Uncertain Clinical Significance Known association with phenotypic abnormality But Also be found in phenotypically normal parents/healthy controls. Therefore likely to be a contributing factor but not in itself sufficient to cause the abnormality 16p11.2 deletion IQ low normal/ mild ID Language difficulties Overweight 16p11.2 duplication Found in normal individuals Increased risk of in dev delay and psychiatric disorders 15q13.3 deletion Found in normal individuals Increased risk of ID, seizures, autism, schizophrenia

16p11.2 Microdeletion syndrome Shinawi M et al. J Med Genet 2010;47:332-341

Novel Copy Number Change of Unknown Significance This is a change which has not been described and verified in the literature, but which contains genes, therefore is potentially relevant. Information to be considered: Size of CNV Inherited vs. de novo If inherited, does it track with phenotype in family? Gene content Information from databases

Benign Copy Number Change These are changes found in phenotypically normal individuals (we all have these) Often located in highly variable regions often containing segmental duplications or repetitive sequences. No known clinical significance Reported as NORMAL.

Workflow used in pathogenicity determination: BC as an example

Probe coverage Known pathogenic regions VCGS data (Red = deletions Blue = duplications) DECIPHER data Haploinsufficiency predictor Gene content CHOP database (2000 normals)

Eur J Med Genet 2009 52: 88-93 Same chromosome region as VCFS/DiGeorge, includes TBX gene Most have mild learning difficulties Some have heart defect/clefting, urogenital abnormalities Some individuals essentially normal Often inherited from a parent Uncertain clinical significance

The chromosome 8 deletion

Browser shot

Interpretation De novo deletion Small number of genes 1 similar case in DECIPHER: SZ, hypotonia No published cases FBXO25 gene widely expressed in brain (animal studies) More information likely to become available in the future, but little prognostication possible for now What is the effect of having two abnormalities?

Clinical challenges for inherited variants of uncertain significance How robust are the data? What is normal? two hit hypothesis Entering field of complex genetics, but only seeing a fraction of contributing genetic factors What is the role of cascade testing Is prenatal diagnosis appropriate?

FOXG1 duplication in father and son with normal intellect Possible explanations Incomplete penetrance Phenotype due to other genes